TalkMed Group Limited (5G3.SI)

0.4150 0.0000 (0.00%) At close: 04:48PM SGT

TalkMed Group Limited

3 Mount Elizabeth
Mount Elizabeth Medical Centre #02-02/03/04
Singapore 228510
Singapore

https://www.talkmed.com.sg

Sector(s): Healthcare
Industry: Medical Care Facilities
Full-time employees: 232

Key executives

Name	Title	Pay	Exercised	Year born
Dr. Peng Tiam Ang	CEO & Executive Director	N/A	N/A	1959
Mr. Boon Yong Lee	Group CFO & Joint Company Secretary	N/A	N/A	N/A
Dr. Kei Siong Khoo	Chief Operating Officer	N/A	N/A	1962
Mr. Heng Chong Lim	Joint Company Secretary	N/A	N/A	N/A
Ms. Jacqueline Anne Low	Joint Company Secretary	N/A	N/A	N/A

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in SGD.

Description

TalkMed Group Limited, an investment holding company, provides medical oncology, stem cell transplants, palliative care, and other related services in Singapore, China, Hong Kong, Vietnam, India, New Zealand, Australia, and the United States. It operates through two segments: Oncology Services; and Cellular and Gene Therapy Related Products and Services. The company offers medical oncology services in the areas of breast, colon, lung, liver, biliary and pancreatic, gastro-intestinal, head and neck, genitourinary and gynaecological, and haematology malignancies and brain cancers, as well as lymphoma and leukaemia. It also provides palliative care services comprising cancer pain management, discharge and home care planning, advance care planning, and end-of-life care planning; and ancillary health services, such as CANSCREEN, a screening program that provides screening for individuals at a risk of getting cancer. In addition, the company offers goods and services related to cellular and gene therapy; specialist doctors and clinical staff services; and healthcare management services. Further, the company develops novel processing platforms for cell and gene therapy and carrying out research in genetic modification of immune cells; and novel platform viral vector technologies that strive to advance genetic modification of cellular therapy through basic vector system design. TalkMed Group Limited was founded in 1997 and is based in Singapore. TalkMed Group Limited operates as a subsidiary of Citibank Nominees Singapore Pte Ltd.

Corporate governance

TalkMed Group Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.